Cargando…

Safety and Efficacy of Daptomycin in Neonates with Coagulase-Negative Staphylococci: Case Series Analysis

There has been an increase in the prevalence of gram-positive bacteremia in neonates in the last two decades. However, as a consequence of better care, there has been an increase in the survival of premature neonates. Coagulase-negative staphylococci (CoNS) is the most prevalent bacteria, responsibl...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohzari, Yahya, Aljobair, Fahad, Alrashed, Ahmed, Asdaq, Syed Mohammed Basheeruddin, Alshuraim, Renad Abdullah, Asfour, Suzan Suhail, Al-Mouqdad, Mountasser Mohammad, Bamogaddam, Reem F., Al-Anazi, Deemah, Zeilinger, Catherine E., Alamer, Ahmad, Alhassan, Batool Mohammed, Sreeharsha, Nagaraja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915314/
https://www.ncbi.nlm.nih.gov/pubmed/33562197
http://dx.doi.org/10.3390/antibiotics10020168
_version_ 1783657209339576320
author Mohzari, Yahya
Aljobair, Fahad
Alrashed, Ahmed
Asdaq, Syed Mohammed Basheeruddin
Alshuraim, Renad Abdullah
Asfour, Suzan Suhail
Al-Mouqdad, Mountasser Mohammad
Bamogaddam, Reem F.
Al-Anazi, Deemah
Zeilinger, Catherine E.
Alamer, Ahmad
Alhassan, Batool Mohammed
Sreeharsha, Nagaraja
author_facet Mohzari, Yahya
Aljobair, Fahad
Alrashed, Ahmed
Asdaq, Syed Mohammed Basheeruddin
Alshuraim, Renad Abdullah
Asfour, Suzan Suhail
Al-Mouqdad, Mountasser Mohammad
Bamogaddam, Reem F.
Al-Anazi, Deemah
Zeilinger, Catherine E.
Alamer, Ahmad
Alhassan, Batool Mohammed
Sreeharsha, Nagaraja
author_sort Mohzari, Yahya
collection PubMed
description There has been an increase in the prevalence of gram-positive bacteremia in neonates in the last two decades. However, as a consequence of better care, there has been an increase in the survival of premature neonates. Coagulase-negative staphylococci (CoNS) is the most prevalent bacteria, responsible for up to 60% of late-onset sepsis (LOS). Daptomycin, a lipopeptide antimicrobial agent, is active against CoNS. This was an observational, retrospective case series study carried out in the Pediatric Hospital of King Saud Medical City, Riyadh, Saudi Arabia. The medical records of 21 neonates, aged 0–28 days, who were treated in Neonatal Intensive Care Unit (NICU) with intravenous daptomycin as monotherapy or combination therapy for at least 4 days for proven gram-positive infection between June 2019 to July 2020, were included. The median gestational and chronological age were 27 weeks and 5 days, respectively. The most frequent diagnosis in neonates was infective endocarditis (42.9%). Of the 21 patients who received daptomycin therapy, 13 (62%) recovered and 8 died. The clinical cure rate was higher in Staphylococcus hominis (100%) and in patients who received 6 mg/kg/dose twice daily (62.5%). The mean of aspartate aminotransferase significantly elevated after starting daptomycin (p = 0.048). However, no muscular or neurological toxicity of daptomycin was documented in any of the cases. Overall, daptomycin was well tolerated, even with long-term treatment.
format Online
Article
Text
id pubmed-7915314
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-79153142021-03-01 Safety and Efficacy of Daptomycin in Neonates with Coagulase-Negative Staphylococci: Case Series Analysis Mohzari, Yahya Aljobair, Fahad Alrashed, Ahmed Asdaq, Syed Mohammed Basheeruddin Alshuraim, Renad Abdullah Asfour, Suzan Suhail Al-Mouqdad, Mountasser Mohammad Bamogaddam, Reem F. Al-Anazi, Deemah Zeilinger, Catherine E. Alamer, Ahmad Alhassan, Batool Mohammed Sreeharsha, Nagaraja Antibiotics (Basel) Article There has been an increase in the prevalence of gram-positive bacteremia in neonates in the last two decades. However, as a consequence of better care, there has been an increase in the survival of premature neonates. Coagulase-negative staphylococci (CoNS) is the most prevalent bacteria, responsible for up to 60% of late-onset sepsis (LOS). Daptomycin, a lipopeptide antimicrobial agent, is active against CoNS. This was an observational, retrospective case series study carried out in the Pediatric Hospital of King Saud Medical City, Riyadh, Saudi Arabia. The medical records of 21 neonates, aged 0–28 days, who were treated in Neonatal Intensive Care Unit (NICU) with intravenous daptomycin as monotherapy or combination therapy for at least 4 days for proven gram-positive infection between June 2019 to July 2020, were included. The median gestational and chronological age were 27 weeks and 5 days, respectively. The most frequent diagnosis in neonates was infective endocarditis (42.9%). Of the 21 patients who received daptomycin therapy, 13 (62%) recovered and 8 died. The clinical cure rate was higher in Staphylococcus hominis (100%) and in patients who received 6 mg/kg/dose twice daily (62.5%). The mean of aspartate aminotransferase significantly elevated after starting daptomycin (p = 0.048). However, no muscular or neurological toxicity of daptomycin was documented in any of the cases. Overall, daptomycin was well tolerated, even with long-term treatment. MDPI 2021-02-07 /pmc/articles/PMC7915314/ /pubmed/33562197 http://dx.doi.org/10.3390/antibiotics10020168 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Mohzari, Yahya
Aljobair, Fahad
Alrashed, Ahmed
Asdaq, Syed Mohammed Basheeruddin
Alshuraim, Renad Abdullah
Asfour, Suzan Suhail
Al-Mouqdad, Mountasser Mohammad
Bamogaddam, Reem F.
Al-Anazi, Deemah
Zeilinger, Catherine E.
Alamer, Ahmad
Alhassan, Batool Mohammed
Sreeharsha, Nagaraja
Safety and Efficacy of Daptomycin in Neonates with Coagulase-Negative Staphylococci: Case Series Analysis
title Safety and Efficacy of Daptomycin in Neonates with Coagulase-Negative Staphylococci: Case Series Analysis
title_full Safety and Efficacy of Daptomycin in Neonates with Coagulase-Negative Staphylococci: Case Series Analysis
title_fullStr Safety and Efficacy of Daptomycin in Neonates with Coagulase-Negative Staphylococci: Case Series Analysis
title_full_unstemmed Safety and Efficacy of Daptomycin in Neonates with Coagulase-Negative Staphylococci: Case Series Analysis
title_short Safety and Efficacy of Daptomycin in Neonates with Coagulase-Negative Staphylococci: Case Series Analysis
title_sort safety and efficacy of daptomycin in neonates with coagulase-negative staphylococci: case series analysis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915314/
https://www.ncbi.nlm.nih.gov/pubmed/33562197
http://dx.doi.org/10.3390/antibiotics10020168
work_keys_str_mv AT mohzariyahya safetyandefficacyofdaptomycininneonateswithcoagulasenegativestaphylococcicaseseriesanalysis
AT aljobairfahad safetyandefficacyofdaptomycininneonateswithcoagulasenegativestaphylococcicaseseriesanalysis
AT alrashedahmed safetyandefficacyofdaptomycininneonateswithcoagulasenegativestaphylococcicaseseriesanalysis
AT asdaqsyedmohammedbasheeruddin safetyandefficacyofdaptomycininneonateswithcoagulasenegativestaphylococcicaseseriesanalysis
AT alshuraimrenadabdullah safetyandefficacyofdaptomycininneonateswithcoagulasenegativestaphylococcicaseseriesanalysis
AT asfoursuzansuhail safetyandefficacyofdaptomycininneonateswithcoagulasenegativestaphylococcicaseseriesanalysis
AT almouqdadmountassermohammad safetyandefficacyofdaptomycininneonateswithcoagulasenegativestaphylococcicaseseriesanalysis
AT bamogaddamreemf safetyandefficacyofdaptomycininneonateswithcoagulasenegativestaphylococcicaseseriesanalysis
AT alanazideemah safetyandefficacyofdaptomycininneonateswithcoagulasenegativestaphylococcicaseseriesanalysis
AT zeilingercatherinee safetyandefficacyofdaptomycininneonateswithcoagulasenegativestaphylococcicaseseriesanalysis
AT alamerahmad safetyandefficacyofdaptomycininneonateswithcoagulasenegativestaphylococcicaseseriesanalysis
AT alhassanbatoolmohammed safetyandefficacyofdaptomycininneonateswithcoagulasenegativestaphylococcicaseseriesanalysis
AT sreeharshanagaraja safetyandefficacyofdaptomycininneonateswithcoagulasenegativestaphylococcicaseseriesanalysis